These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14262418)

  • 1. [ON THE EFFECT OF ANTIBIOTICS INHIBITING THE CELL WALL ON GRAM-NEGATIVE BACTERIA. II. THE EFFECT OF D-CYCLOSERINE ON THE CONCENTRATION OF CELL WALL PRECURSORS IN PROTEUS MIRABILIS AND ITS L-PHASE].
    PLAPP R; KANDLER O
    Arch Mikrobiol; 1965 Feb; 50():282-97. PubMed ID: 14262418
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE MECHANISM OF ACTION OF CELL WALL-INHIBITING ANTIBIOTICS IN GRAM NEGATIVE BACTERIA. I. THE EFFECT OF PENICILLIN ON THE CONCENTRATION OF CELL WALL PRECURSORS IN PROTEUS MIRABILIS].
    PLAPP R; KANDLER O
    Arch Mikrobiol; 1965 Jan; 50():171-93. PubMed ID: 14304667
    [No Abstract]   [Full Text] [Related]  

  • 3. L PHASE VARIANTS RELATED TO ANTIBIOTIC INHIBITION OF CELL WALL BIOSYNTHESIS.
    KRAWITT EL; WARD JR
    Proc Soc Exp Biol Med; 1963 Dec; 114():629-31. PubMed ID: 14120310
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations on the effect of penicillin and of other antibiotics on L forms of Proteus mirabilis].
    HOROSZEWICZ A; HOROSZEWICZ J
    Acta Microbiol Pol (1952); 1956; 5(1-2):9-14. PubMed ID: 13394215
    [No Abstract]   [Full Text] [Related]  

  • 5. PREDOMINANT CHARACTERISTICS OF THE GROWTH OF SOME ANTIBIOTIC-INDUCED L-PHASE BACTERIA.
    GODZESKI CW; HISKER RM; BRIER G
    Antimicrob Agents Chemother (Bethesda); 1963; 161():507-16. PubMed ID: 14274952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the mode of action of aureomycin and mexocine in Proteus mirabilis].
    GUILLAUME J; OSTEUX R; WATTEL F; DESCHAMPS F
    C R Seances Soc Biol Fil; 1962; 156():1829-32. PubMed ID: 13963406
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.
    TAUBENECK U
    Nature; 1962 Oct; 196():195-6. PubMed ID: 13993473
    [No Abstract]   [Full Text] [Related]  

  • 8. ANTIBIOTIC THERAPY IN ESTABLISHED CHRONIC EXPERIMENTAL PROTEUS MIRABILIS PYELONEPHRITIS.
    HUNTER BW; SOUDA LL; SANFORD JP
    Antimicrob Agents Chemother (Bethesda); 1963; 161():608-12. PubMed ID: 14274971
    [No Abstract]   [Full Text] [Related]  

  • 9. Envelope structure in three different L-forms of Proteus mirabilis.
    Demonty JA; Robaye B; Calberg-Bacq CM
    Antonie Van Leeuwenhoek; 1973; 39(2):217-28. PubMed ID: 4578056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance in vitro to antibiotics of gram-negative bacteria: Escherichia, Aerobacter, Proteus, Pseudomonas].
    ZOCCHI S
    Boll Soc Ital Biol Sper; 1960 Feb; 36():136-8. PubMed ID: 13847695
    [No Abstract]   [Full Text] [Related]  

  • 11. ACTIVITY OF AMPICILLIN ALONE AND IN COMBINATION WITH CHLORAMPHENICOL OR STREPTOMYCIN AGAINST PROTEUS MIRABILIS IN VIVO AND IN VITRO.
    STRAUS AL; FLEMING T
    Antimicrob Agents Chemother (Bethesda); 1964; 10():268-73. PubMed ID: 14287942
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPOSITION OF THE MUCOPOLYMER IN CELL WALLS OF THE UNSTABLE AND STABLE L-FORM OF PROTEUS MIRABILIS.
    MARTIN HH
    J Gen Microbiol; 1964 Sep; 36():441-50. PubMed ID: 14217356
    [No Abstract]   [Full Text] [Related]  

  • 13. [CORRELATION OF THE ANTIVIRAL AGENT I914-VUFB WITH THE BACTERICIDAL EFFECTIVENESS OF SOME ANTIBIOTICS].
    NEZVAL J
    Scr Med (Brno); 1964; 37():257-62. PubMed ID: 14204293
    [No Abstract]   [Full Text] [Related]  

  • 14. LABORATORY STUDIES ON GENTAMICIN.
    RUBENIS M; KOZIJ VM; JACKSON GG
    Antimicrob Agents Chemother (Bethesda); 1963; 161():153-6. PubMed ID: 14274883
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the possible anti-mitotic action of cycloserine and kanamycin. Experimental research].
    MONCALVO F; GIORDANO M; MOREO GC; RONDANELLI R
    G Ital Tuberc Mal Torace; 1960; 14():15-22. PubMed ID: 14423506
    [No Abstract]   [Full Text] [Related]  

  • 16. METABOLIC PROPERTIES OF SOME L FORMS DERIVED FROM GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA.
    WEIBULL C; GYLLANG H
    J Bacteriol; 1965 Jun; 89(6):1443-7. PubMed ID: 14291577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELECTRON MICROSCOPY OF THE EFFECT OF "SEPTONEX" ON THE CELL WALL AND SPHEROPLAST MEMBRANE OF PROTEUS VULGARIS.
    NERMUT MV
    Z Allg Mikrobiol; 1964; 4():92-4. PubMed ID: 14300654
    [No Abstract]   [Full Text] [Related]  

  • 18. [COMPOSITION OF THE CELL WALL SUPPORTING MEMBRANE OF NORMAL CELLS AND PENICILLIN SPHEROPLASTS OF PROTEUS MIRABILIS].
    MARTIN HH
    Zentralbl Bakteriol Orig; 1963 Dec; 191():409-14. PubMed ID: 14119935
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METHODS FOR MEASURING INHIBITION BY D-CYCLOSERINE OF ENZYMATIC REACTIONS ESSENTIAL FOR BACTERIAL CELL WALL SYNTHESIS.
    STROMINGER JL
    Methods Med Res; 1964; 10():245-6. PubMed ID: 14284927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.